Roche Holdings Ltd Sponsored ADR (RHHBY)


Roche Holding AG's principle activities are divided into three divisions: Pharmaceuticals: prescription products and over the counter pharmaceutical products; Diagnostics: reagents and test kits for molecular and cell biology, analytical systems and reagents for clinical chemistry, immunochemistry, hematology and coagulation; Vitamins and fine chemicals: vitamin supplements for the animal feed, food, pharmaceuticals and cosmetics industries. A decision was taken to sell the vitamins and fine chemicals division to the DSM Group (The Netherlands) in August 2002, the sale should be complete during the first half of 2003. Pharmaceuticals accounted for 64% of 2002 revenues; diagnostics, 24% and vitamins and fine chemicals, 12%.

Data based on most recent fiscal year report
Market Cap290.718 Billion Shares Outstanding6.848 Billion Avg Volume1.613 Million
1-Yr BETA vs S&P TR0.77 Current Ratio1.4 Quick Ratio1.11
View SEC Filings from RHHBY instead.

Funds Holding RHHBY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RHHBY BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)


Open Market Sells (S)


Exercise Derivative Conversion (M)


Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments